Publication:
Drug survival of dupilumab, tralokinumab and upadacitinib in patients with atopic dermatitis: An international, real-world comparative study.

cris.virtualsource.author-orcid4090fa43-6e34-4be3-a58c-2102e3bc80c9
datacite.rightsrestricted
dc.contributor.authorTorres, Tiago
dc.contributor.authorYeung, Jensen
dc.contributor.authorPrajapati, Vimal
dc.contributor.authorRibero, Simone
dc.contributor.authorBalato, Anna
dc.contributor.authorValerio Marzano, Angelo
dc.contributor.authorCruz, Maria João
dc.contributor.authorPaiva Lopes, Maria João
dc.contributor.authorLazaridou, Elizabeth
dc.contributor.authorCarrascosa, Jose-Manuel
dc.contributor.authorAlvarenga, José Miguel
dc.contributor.authorFarinha, Pedro
dc.contributor.authorDuarte, Bruno
dc.contributor.authorSood, Siddhartha
dc.contributor.authorRankin, Brian D
dc.contributor.authorOrtoncelli, Michela
dc.contributor.authorCaccavale, Stefano
dc.contributor.authorFerrucci, Silvia Mariel
dc.contributor.authorRosa, Gilberto Pires
dc.contributor.authorDaponte, Athina Ioanna
dc.contributor.authorSilvi, Gianmarco
dc.contributor.authorPeris, Ketty
dc.contributor.authorGori, Niccolò
dc.contributor.authorHerranz, Pedro
dc.contributor.authorPrignano, Francesca
dc.contributor.authorKolios, Antonio
dc.contributor.authorRompoti, Natalia
dc.contributor.authorGkalpakiotis, Spyridon
dc.contributor.authorChiricozzi, Andrea
dc.date.accessioned2025-02-25T11:28:20Z
dc.date.available2025-02-25T11:28:20Z
dc.date.issued2025-02-06
dc.description.sponsorshipClinic of Dermatology
dc.identifier.doi10.48620/85500
dc.identifier.pmid39912554
dc.identifier.publisherDOI10.1111/jdv.20581
dc.identifier.urihttps://boris-portal.unibe.ch/handle/20.500.12422/205107
dc.language.isoen
dc.publisherWiley
dc.relation.ispartofJournal of the European Academy of Dermatology and Venereology
dc.relation.issn1468-3083
dc.relation.issn0926-9959
dc.subject.ddc600 - Technology::610 - Medicine & health
dc.titleDrug survival of dupilumab, tralokinumab and upadacitinib in patients with atopic dermatitis: An international, real-world comparative study.
dc.typearticle
dspace.entity.typePublication
dspace.file.typetext
oairecerif.author.affiliationClinic of Dermatology
unibe.contributor.roleauthor
unibe.contributor.roleauthor
unibe.contributor.roleauthor
unibe.contributor.roleauthor
unibe.contributor.roleauthor
unibe.contributor.roleauthor
unibe.contributor.roleauthor
unibe.contributor.roleauthor
unibe.contributor.roleauthor
unibe.contributor.roleauthor
unibe.contributor.roleauthor
unibe.contributor.roleauthor
unibe.contributor.roleauthor
unibe.contributor.roleauthor
unibe.contributor.roleauthor
unibe.contributor.roleauthor
unibe.contributor.roleauthor
unibe.contributor.roleauthor
unibe.contributor.roleauthor
unibe.contributor.roleauthor
unibe.contributor.roleauthor
unibe.contributor.roleauthor
unibe.contributor.roleauthor
unibe.contributor.roleauthor
unibe.contributor.roleauthor
unibe.contributor.roleauthor
unibe.contributor.roleauthor
unibe.contributor.roleauthor
unibe.contributor.roleauthor
unibe.description.ispublishedinpress
unibe.refereedtrue
unibe.subtype.articlecontribution

Files

Original bundle
Now showing 1 - 1 of 1
Name:
Acad Dermatol Venereol - 2025 - Torres - Drug survival of dupilumab tralokinumab and upadacitinib in patients with atopic.pdf
Size:
286.67 KB
Format:
Adobe Portable Document Format
File Type:
text
Content:
published

Collections